BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17252190)

  • 1. The roles of acid-sensing ion channel 1a and ovarian cancer G protein-coupled receptor 1 on passive Mg2+ transport across intestinal epithelium-like Caco-2 monolayers.
    Thongon N; Ketkeaw P; Nuekchob C
    J Physiol Sci; 2014 Mar; 64(2):129-39. PubMed ID: 24375028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal absorption of bioactive oligopeptides: paracellular transport and tight junction modulation.
    Yu Z; Liu D; Wu C; Zhao W
    Food Funct; 2024 May; ():. PubMed ID: 38787733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption and transport properties of a codfish-derived peptide and its protective effect on bone loss in ovariectomized mice.
    Yang M; Su S; Cheng S; Wang Z; Du M
    Food Funct; 2024 Apr; 15(7):3496-3506. PubMed ID: 38463011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracellular absorption is relatively low in the herbivorous Egyptian spiny-tailed lizard, Uromastyx aegyptia.
    McWhorter TJ; Pinshow B; Karasov WH; Tracy CR
    PLoS One; 2013; 8(4):e61869. PubMed ID: 23596529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa.
    Palić S; Kip AE; Beijnen JH; Mbui J; Musa A; Solomos A; Wasunna M; Olobo J; Alves F; Dorlo TPC
    J Antimicrob Chemother; 2020 Nov; 75(11):3260-3268. PubMed ID: 32780098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and Antiparasitic Activity Relationship of Alkylphosphocholine Analogues against
    Ahmed H; Carter KC; Williams RAM
    Microorganisms; 2020 Jul; 8(8):. PubMed ID: 32722326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.
    Botschuijver S; van Diest SA; van Thiel IAM; Saia RS; Strik AS; Yu Z; Maria-Ferreira D; Welting O; Keszthelyi D; Jennings G; Heinsbroek SEM; Elferink RPO; Schuren FHJ; de Jonge WJ; van den Wijngaard RM
    Sci Rep; 2019 Aug; 9(1):12530. PubMed ID: 31467355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Nonviral Gene Delivery for Chronic Protein Replacement Therapy.
    Lin PY; Chiu YL; Huang JH; Chuang EY; Mi FL; Lin KJ; Juang JH; Sung HW; Leong KW
    Adv Sci (Weinh); 2018 Aug; 5(8):1701079. PubMed ID: 30128227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure-response relationships.
    Kip AE; Castro MDM; Gomez MA; Cossio A; Schellens JHM; Beijnen JH; Saravia NG; Dorlo TPC
    J Antimicrob Chemother; 2018 Aug; 73(8):2104-2111. PubMed ID: 29757380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages: IMPACT ON INTRACELLULAR SURVIVAL OF LEISHMANIA (VIANNIA) PANAMENSIS.
    Dohmen LC; Navas A; Vargas DA; Gregory DJ; Kip A; Dorlo TP; Gomez MA
    J Biol Chem; 2016 Apr; 291(18):9638-47. PubMed ID: 26903515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of miltefosine in peripheral blood mononuclear cells by high-performance liquid chromatography-tandem mass spectrometry.
    Kip AE; Rosing H; Hillebrand MJ; Castro MM; Gomez MA; Schellens JH; Beijnen JH; Dorlo TP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 998-999():57-62. PubMed ID: 26160472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro transport characteristics of EFdA, a novel nucleoside reverse transcriptase inhibitor using Caco-2 and MDCKII cell monolayers.
    Zhang W; Parniak MA; Sarafianos SG; Empey PE; Rohan LC
    Eur J Pharmacol; 2014 Jun; 732():86-95. PubMed ID: 24690257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-epithelial transport of the betalain pigments indicaxanthin and betanin across Caco-2 cell monolayers and influence of food matrix.
    Tesoriere L; Gentile C; Angileri F; Attanzio A; Tutone M; Allegra M; Livrea MA
    Eur J Nutr; 2013 Apr; 52(3):1077-87. PubMed ID: 22806766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal absorption of miltefosine: contribution of passive paracellular transport.
    Ménez C; Buyse M; Dugave C; Farinotti R; Barratt G
    Pharm Res; 2007 Mar; 24(3):546-54. PubMed ID: 17252190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of intestinal barrier properties by miltefosine.
    Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
    Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inward translocation of the phospholipid analogue miltefosine across Caco-2 cell membranes exhibits characteristics of a carrier-mediated process.
    Ménez C; Buyse M; Farinotti R; Barratt G
    Lipids; 2007 Apr; 42(3):229-40. PubMed ID: 17393228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
    Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular transport and lipid interactions of miltefosine.
    Barratt G; Saint-Pierre-Chazalet M; Loiseau PM
    Curr Drug Metab; 2009 Mar; 10(3):247-55. PubMed ID: 19442087
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.